| |
Hepatology
AU- Chalasani, N., and A. Baluyut and A. Ismail and A. Zaman and G. Sood and R. Ghalib and T.M. McCashland and K.R. Reddy and X. Zervos and M.A. Anbari and H. Hoen
TI- "Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study."
SO- Hepatology 31, no. 1 (2000): 7-11.
UM- mdd-Reddy, K. Rajender / AU- Di Bisceglie, A.M., and H.L. Bonkovsky and S. Chopra and S. Flamm and R.K. Reddy and N. Grace and P. Killenberg and C. Hunt and C. Tamburro and A.S. Tavill and R. Ferguson and E. Krawitt and B. Banner and B.R. Bacon
TI- "Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial."
SO- Hepatology 32, no. 1 (2000): 135-138.
UM- mdd-Reddy, K. Rajender / AU- Dienstag, J.L., and E.R. Schiff and M. Mitchell and D.E. Casey and N. Gitlin and T. Lissoos and L.D. Gelb and L. Condreay and L. Crowther and M. Rubin and N. Brown
TI- "Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy."
SO- Hepatology 30, no. 4 (1999): 1082-1087.
UM- mdd-Schiff, Eugene R. / AU- Hammond, C., and L.J. Jeffers and B.I. Carr and D. Simon
TI- "Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma."
SO- Hepatology 29, no. 5 (1999): 1479-1485.
UM- mdd-Jeffers, Lennox J. / AU- Heathcote, E.J.L., and E.B. Keeffe and S.S. Lee and S.V. Feinman and M.J. Tong and K.R. Reddy and D.G. Albert and K. Witt and L.M. Blatt
TI- "Re-treatment of chronic hepatitis C with consensus interferon."
SO- Hepatology 27, no. 4 (1998): 1136-1143.
UM- mdd-Reddy, K. Rajender / AU- Lee, W.M., and K.R. Reddy and M.J. Tong and M. Black and D.J. van Leeuwen and F.B. Hollinger and K.D. Mullen and N. Pimstone and D. Albert and S. Gardner
TI- "Early hepatitis C virus RNA responses predict interferon treatment outcomes in chronic hepatitis C."
SO- Hepatology 28, no. 5 (1998): 1411-1415.
UM- mdd-Reddy, K. Rajender / AU- Lindsay, K.L., and C. Trepo and T. Heintges and M.L. Shiffman and S.C. Gordon and J.C. Hoefs and E.R. Schiff and Z.D. Goodman and M. Laughlin and R.J. Yao and J.K. Albrecht
TI- "A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C."
SO- Hepatology 34, no. 2 (2001): 395-403.
UM- mdd-Schiff, Eugene R. / AU- Perrillo, R., and J. Rakela and J. Dienstag and G. Levy and P. Martin and T. Wright and S. Caldwell and E.R. Schiff and R. Gish and J.P. Villeneuve and G. Farr and G. Anschuetz and L. Crowther and N. Brown
TI- "Multicenter study of lamivudine therapy for hepatitis B after liver transplantation."
SO- Hepatology 29, no. 5 (1999): 1581-1586.
UM- mdd-Schiff, Eugene R. / AU- Perrillo, R., and E.R. Schiff and E. Yoshida and A. Statler and K. Hirsch and T. Wright and K. Gutfreund and P. Lamy and A. Murray
TI- "Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants."
SO- Hepatology 32, no. 1 (2000): 129-134.
UM- mdd-Schiff, Eugene R. / AU- Perrillo, R.P., and C.L. Lai and Y.F. Liaw and J.L. Dienstag and E.R. Schiff and S.W. Schalm and E.J. Heathcote and N.A. Brown and M. Atkins and M. Woessner and S.D. Gardner
TI- "Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B."
SO- Hepatology 36, no. 1 (2002): 186-194.
UM- mdd-Schiff, Eugene R. / AU- Perrillo, R.P., and T. Wright and J. Rakela and G. Levy and E.R. Schiff and R. Gish and P. Martin and J. Dienstag and P. Adams and R. Dickson and G. Anschuetz and S. Bell and L. Condreay and N. Brown
TI- "A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis."
SO- Hepatology 33, no. 2 (2001): 424-432.
UM- mdd-Schiff, Eugene R. / AU- Reddy, K.R., and J.H. Hoofnagle and M.J. Tong and W.M. Lee and P. Pockros and E.J. Heathcote and D. Albert and T. Joh
TI- "Racial differences in responses to therapy with interferon in chronic hepatitis C."
SO- Hepatology 30, no. 3 (1999): 787-793.
UM- mdd-Reddy, K. Rajender / AU- Reddy, K.R., and J.H. Hoofnagle and M.J. Tong and W.M. Lee and P. Pockros and E.J. Heathcote and D. Albert and T. Joh
TI- "Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group."
SO- Hepatology 30, no. 3 (1999 Sep): 787-793.
UM- mdd-Reddy, K. Rajender / AU- Reddy, K.R., and T.L. Wright and P.J. Pockros and M. Shiffman and G. Everson and R. Reindollar and M.W. Fried and P.P. Purdum and D. Jensen and C. Smith and W.M. Lee and T.D. Boyer and A. Lin and S. Pedder and J. DePamphilis
TI- "Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C."
SO- Hepatology 33, no. 2 (2001): 433-438.
UM- mdd-Reddy, K. Rajender / AU- Strasser, S.I., and H.M. Shulman and M.E. Flowers and K. Reddy and D.A. Margolis and M. Prumbaum and S.E. Seropian and G.B. McDonald
TI- "Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis."
SO- Hepatology 32, no. 6 (2000): 1265-1271.
UM- psi-Baum, Marianna K. /
|
 |
|
|
